BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27321864)

  • 1. The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.
    Monti JM; Torterolo P; Pandi Perumal SR
    Sleep Med Rev; 2017 Jun; 33():51-57. PubMed ID: 27321864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
    Cohrs S
    CNS Drugs; 2008; 22(11):939-62. PubMed ID: 18840034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep in schizophrenia patients and the effects of antipsychotic drugs.
    Monti JM; Monti D
    Sleep Med Rev; 2004 Apr; 8(2):133-48. PubMed ID: 15033152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature.
    Kluge M; Schacht A; Himmerich H; Rummel-Kluge C; Wehmeier PM; Dalal M; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T; Schuld A
    Schizophr Res; 2014 Jan; 152(1):255-60. PubMed ID: 24315135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
    Giménez S; Clos S; Romero S; Grasa E; Morte A; Barbanoj MJ
    Psychopharmacology (Berl); 2007 Mar; 190(4):507-16. PubMed ID: 17205319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia.
    Ishida T; Obara Y; Kamei C
    J Pharmacol Sci; 2009 Sep; 111(1):44-52. PubMed ID: 19721330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder.
    Monti JM
    Sleep Med; 2016 Jul; 23():89-96. PubMed ID: 27692282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep quality in schizophrenia and the effects of atypical antipsychotic medication.
    Haffmans PM; Oolders HJ; Hoencamp E; Schreiner A
    Acta Neuropsychiatr; 2004 Dec; 16(6):281-9. PubMed ID: 26984540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone suppresses rapid eye movement sleep and improves sleep quality in rats.
    Murai T; Nakamichi K; Shimizu I; Ikeda K
    J Pharmacol Sci; 2014; 126(2):164-7. PubMed ID: 25231559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine.
    Kluge M; Himmerich H; Wehmeier PM; Rummel-Kluge C; Dalal M; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T; Schuld A
    Schizophr Res; 2012 Mar; 135(1-3):123-7. PubMed ID: 22257975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on sleep: a longitudinal study.
    Hinze-Selch D; Mullington J; Orth A; Lauer CJ; Pollmächer T
    Biol Psychiatry; 1997 Aug; 42(4):260-6. PubMed ID: 9270902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive polysomnographic traits in nocturnal frontal lobe epilepsy.
    Parrino L; De Paolis F; Milioli G; Gioi G; Grassi A; Riccardi S; Colizzi E; Terzano MG
    Epilepsia; 2012 Jul; 53(7):1178-84. PubMed ID: 22578113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic medications and sleep problems in patients with schizophrenia.
    Cederlöf E; Holm M; Taipale H; Tiihonen J; Tanskanen A; Lähteenvuo M; Lahdensuo K; Kampman O; Wegelius A; Isometsä E; Kieseppä T; Palotie A; Suvisaari J; Paunio T;
    Schizophr Res; 2024 May; 267():230-238. PubMed ID: 38579432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic Treatment of the Adult Patient in the Acute Phase of Schizophrenia].
    Bohórquez Peñaranda A; Gómez Restrepo C; García Valencia J; Jaramillo González LE; de la Hoz AM; Arenas Á; Tamayo Martínez N
    Rev Colomb Psiquiatr; 2014; 44 Suppl 1():13-28. PubMed ID: 26576459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumateperone (Caplyta) for schizophrenia.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):113-116. PubMed ID: 32728011
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients.
    Salín-Pascual RJ; Herrera-Estrella M; Galicia-Polo L; Rosas M; Brunner E
    Rev Invest Clin; 2004; 56(3):345-50. PubMed ID: 15612518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.